光滑表面组织扩张器乳房重建的安全性与有效性
本研究回顾性分析了3家机构2016至2017年连续112例接受光滑表面组织扩张器(STE)即刻乳房重建的患者,共173个装置,平均随访14.1个月。总体并发症率为15.6%,包括皮瓣坏死10.4%、血清肿5.2%、扩张器移位2.9%和需静脉抗生素的感染3.5%;3.5%因感染或改变计划行非计划再手术取出。作者认为STE是安全有效的替代选择,结局至少不劣于纹理面扩张器,值得前瞻性随机对照研究。
要点
- STE乳房重建总体并发症率15.6%,感染需静脉抗生素者3.5%。
- 非计划再手术取出率3.5%,因感染和改变计划各3例。
- 技术改良包括固定片固定、严格囊袋控制、术后文胸支撑和缝线选择。
核心结论
- 光滑表面组织扩张器是安全有效的乳房重建替代选择,结局至少不劣于纹理面扩张器。
- 早期感染控制和取出率结果令人鼓舞,需前瞻性随机试验比较其潜在优势。
研究设计与样本
- 回顾性研究,纳入2016至2017年3家机构连续接受光滑表面组织扩张器乳房重建的女性。
- 共112例患者、173个装置,平均随访14.1个月;75例胸肌下、37例胸肌前放置。
主要发现
- 患者平均年龄53岁,平均BMI 27.2 kg/m2,18.6%接受乳房切除术后放疗。
- 总体并发症率15.6%,包括皮瓣坏死10.4%、血清肿5.2%、扩张器移位2.9%、需静脉抗生素感染3.5%。
- 6例(3.5%)非计划再手术取出,其中3例感染、3例改变计划未重建。
临床怎么用
- 可考虑将光滑表面组织扩张器用于即刻乳房重建,尤其关注感染和取出风险。
- 采用固定片固定、严格囊袋控制、术后文胸支撑和合理缝线选择可能改善结局。
局限性
- 回顾性设计,无纹理面扩张器对照组,样本量有限,随访时间较短。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Traditional 2-stage breast reconstruction involves placement of a textured-surface tissue expander (TTE). Recent studies have demonstrated textured surface devices have higher propensity for bacterial contamination and biofilm formation. OBJECTIVES: The purpose of this study was to evaluate the safety and efficacy of smooth surface tissue expanders (STE) in immediate breast reconstruction. METHODS: The authors retrospectively reviewed consecutive women who underwent STE breast reconstruction from 2016 to 2017 at 3 institutions. Indications and outcomes were evaluated. RESULTS: A total 112 patients underwent STE reconstruction (75 subpectoral, 37 prepectoral placement), receiving 173 devices and monitored for a mean follow-up of 14.1 months. Demographics of patients included average age of 53 years and average BMI of 27.2 kg/m2, and 18.6% received postmastectomy radiation therapy. Overall complication rates were 15.6% and included mastectomy skin flap necrosis (10.4%), seroma (5.2%), expander malposition (2.9%), and infection requiring intravenous antibiotic therapy (3.5%). Six (3.5%) unplanned reoperations with explantation were reported for 3 infections and 3 patients requesting change of plan with no reconstruction. CONCLUSIONS: STEs represent a safe and efficacious alternative to TTE breast reconstruction with at least equitable outcomes. Technique modification including tab fixation, strict pocket control, postoperative bra support, and suture choice may contribute to observed favorable outcomes and are reviewed. Early results for infection control and explantation rate are encouraging and warrant comparative evaluation for potential superiority over TTEs in a prospective randomized trial.
引用
- Fairchild B, Ellsworth W, Selber JC, et al. Safety and Efficacy of Smooth Surface Tissue Expander Breast Reconstruction. Aesthet Surg J. 2020. PMID: 30107477. doi:10.1093/asj/sjy199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。